MatteoTruccoMD

Pediatric Hematology & Oncology • Cleveland, OH

Pediatric Hematologic Oncology, Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Associate Professor of Pediatrics Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland Clinic Children’s Director Children’s Cancer Innovative Therapy Program

Join to view full profile

Dr. Trucco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Trucco's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 216-444-2200

Summary

Dr. Matteo Trucco is a pediatric hematologist/oncologist at the Cleveland Clinic in Cleveland, OH specializing in pediatric sarcomas and the development on new treatments for childhood cancers. He received his medical degree from Temple University School of Medicine and has been in practice 11 years. He also speaks multiple languages, including Spanish and Italian. He is involved in several organization whose mission is to improve the outcomes for children battling cancer including the National Pediatric Cancer Foundation, MIB Agents and the SebastianStrong Foundation.

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2009 - 2012
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2006 - 2009
Lewis Katz School of Medicine at Temple UniversityClass of 2006
University of PennsylvaniaBA, Biology, Philosophy of Science, 1997 - 2001

Certifications & Licensure

OH State Medical License 2006 - 2025
FL State Medical License 2016 - 2020
TX State Medical License 2012 - 2017
MD State Medical License 2009 - 2013
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
Completed
Phase 2
Dendritic Cell Vaccine for Children and Adults With Sarcoma Start of enrollment: 2014 Jan 06
Active, not recruiting
Phase 1
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Start of enrollment: 2016 Apr 19
Completed
Phase 2
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations Start of enrollment: 2020 Mar 12
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Fou...
Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M Loeb
Clinical Cancer Research. 2024-12-02
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.
Ajay Gupta, Matthew S Dietz, Richard F Riedel, Aditi Dhir, Scott C Borinstein
Cancer. 2024-12-01
Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" Cases.
Josephine K Dermawan, Faizan Malik, John M Gross, Ezra Baraban, Christine Pratilas
Modern Pathology. 2024-11-01

Press Mentions

Cleveland Clinic Hosts 2nd Annual Virtual Head-Shaving Event for Childhood Cancer ResearchMay 16th, 2021
SebastianStrong Awards $225,000 Discovery Science Grant for Childhood Brain Cancer ResearchAugust 7th, 2020
Your Child Has Been Diagnosed with Cancer. Don’t Panic. Smart Treatments AboundJuly 27th, 2018
Join now to see all